Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy
Release Date:
Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker's CEO appeared on Capitol Hill Tuesday to face questions about why those prices are so high. William Brangham reports. PBS News is supported by - https://www.pbs.org/newshour/about/funders
Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy